Moving from 5mg to 7.5mg Mounjaro: the dose increase explained

How the SURMOUNT trial data frames dose increases

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity across the tirzepatide dose range. A central finding was that weight reduction continued to build as doses increased, with participants at 15mg achieving around 20–21% average body-weight loss over 72 weeks. Importantly, no single dose switch is a reset point, the titration is one continuous clinical process, and the jump from 5mg to 7.5mg sits in the phase where many people's appetite suppression begins to deepen noticeably, something our page on going up to 7.5mg Mounjaro explores in more detail.

The licensed schedule exists because dose escalation, done in four-week steps, reduces the likelihood of significant gastrointestinal side effects. Rushing the schedule does not produce faster results; it tends to produce more nausea. That is why the SmPC on the Electronic Medicines Compendium specifies the minimum interval between increases, and why a prescriber's sign-off is required before each step.

One thing worth flagging: some people do experience a brief return of nausea or looser stools in the first one to two weeks at 7.5mg, even if 5mg became comfortable. This is a recognised pattern across GLP-1 and dual-agonist medicines, the body is adjusting to a new level of gastric-emptying slowdown. It typically settles. If it does not, that is a conversation for your prescriber, not a reason to stop unilaterally.

What your prescriber is looking for before approving 7.5mg

A prescriber reviewing a request to move from 5mg to 7.5mg Mounjaro will usually want to know two things: that you have completed at least four weeks at 5mg, and that the dose was tolerated without persistent, severe or unmanageable side effects. Beyond tolerability, they may weigh the weight-loss trajectory, if 5mg has produced a good response, the case for increasing is strong; if response has plateaued, moving up can re-establish it, and our page on going up to 5mg Mounjaro gives useful context on what that earlier response phase typically looks like.

At nume, every repeat and dose-increase request is reviewed by a GPhC-registered Independent Prescriber. A real clinician reads your case, not an automated queue. For dose increases specifically, our prescribers ask for evidence of current treatment before approving the next step, which is why the clinical re-review is central to the process rather than optional. You can read more about how the titration looks before 5mg on our 2.5mg to 5mg step page.

One practical note: if you are wondering whether the 5mg you have left in a 7.5mg pen can be used differently, that is a separate and specific question, our page on whether you can dose 5mg from a 7.5mg pen covers the clinical position on that directly.

Side effects to be aware of at this step

The most commonly reported side effects of tirzepatide are gastrointestinal: nausea, vomiting, diarrhoea, constipation, reflux and burping. The NHS tirzepatide medicines page lists these in full and explains which are common versus rare. At 7.5mg, the GI picture is broadly the same as at lower doses, though individual experience varies considerably, some people find the step very smooth, others find the first week noticeably harder than anything they experienced at 2.5mg or 5mg.

Severe or persistent stomach pain (particularly pain that radiates to the back) warrants prompt medical attention because it can indicate pancreatitis, a known but uncommon risk with GLP-1 medicines that the MHRA has highlighted in its safety communications. Do not try to manage that kind of pain by adjusting your injection timing. Seek medical help and report any suspected side effects through the MHRA Yellow Card scheme.

Hydration matters more than many people expect at this stage. Reduced appetite often means reduced fluid intake, which compounds any GI discomfort. Protein adequacy is worth keeping an eye on too, smaller portions can quietly reduce intake, and muscle is worth protecting during weight loss. If you are also curious about the practicalities of measuring your dose, our page on how many mg is 100 units of tirzepatide explains the conversion clearly. Specific nutritional targets for your situation are a prescriber or dietitian conversation, not something to set from a webpage.

What happens after 7.5mg, and how to think about where you are heading

If 7.5mg is well-tolerated and producing results, the next potential step is 10mg. Our 7.5mg to 10mg page covers what that transition looks like. Whether to continue increasing depends on your response and side-effect profile at each dose; some people maintain effectively at 7.5mg or 10mg without needing the higher strengths. That is a decision made with your prescriber, not a ladder to climb as quickly as possible.

If you are thinking about the cost picture as doses change, our weight-loss treatment overview gives honest context on what to factor in across the titration journey.

The pen that arrives at this step is the same Mounjaro KwikPen format, four weekly doses, in plain unbranded packaging via DPD tracked delivery. The dose on the label changes; everything else about how it works is the same. If you have questions about your current treatment or are ready to request a dose review, our prescribers are available every day. Start your free consultation and a prescriber will review your case the same day.